Biodesix
BDSX
$1.24
Share price
-1.98%
Change (1 day)
-31.39%
Change (1 year)
Categories
Biodesix (BDSX) - Cash on Hand
Cash on Hand as of December 2023 : $26.28 M
According to Biodesix's latest financial reports the company has $26.28 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Biodesix - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $26.28 M | -39% |
| 2022-12-31 | $43.08 M | 31.72% |
| 2021-12-31 | $32.71 M | -47.35% |
| 2020-12-31 | $62.12 M | 1075.29% |
| 2019-12-31 | $5.28 M | -10.62% |
| 2018-12-31 | $5.91 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 LabCorp LH | $0.53 B | 1,942.31% | 🇺🇸 USA |
 OpGen
OPGN | $0.29 M | -98.89% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.41 B | 1,479.68% | 🇺🇸 USA |